These studies confirm that the AR47.47 variable regions are capable of binding antigen in the context of a human IgE molecule.
BN rats are immunocompetent and express the BR96 binding antigen in normal tissues, mainly in the epithelium of the gastrointestinal tract [17], similar to humans.
Therefore, bound antigens should be almost opposed in the diabody, and in a small circular area in the minibody, which actually precludes the binding to the second antigen in a number of situations.
For example, erythrocyte binding antigens, stored in micronemes, are released prior to invasion and allow host cell recognition, while rhoptry proteins stored in rhoptries are release later and are believed to participate in parasitophorous vacuole formation [ 8].
We did not run an SDS-PAGE to show that the antibody remains intact as the radiolabeled antibody is still able to bind >99 % to Sn antigen which is completely blocked by cold antigen in a competitive binding assay.
The AB loop, which can be engineered for the contribution to antigen binding in an Fcab as well, is hardly affected.
Overall, magnetic beads enrichment combined with FACS sorting of high antigen binding/ZsGreen expressing cells resulted in a 106 fold-enrichment of antigen binding cells in a tandem two-step round of selection.
The Lewis Y antigen is expressed on the majority of human epithelial tumors, but normal human tissue also contains the BR96-binding antigen, primarily in the epithelial cells of the gastrointestinal tract [13].
To overcome these challenges, we have engineered a tetravalent bsAb with bivalent binding specificity for the CD20 and CD3 antigen in an immunoglobulin G (IgG) format.
It provides the molecule with flexibility, which is very useful in binding antigens.
